Stem cell therapy for knee cartilage repair, not approved as a mainstream treatment in Singapore, is driving Singaporeans to Malaysia to seek treatments. But the risks of complications and challenges with aftercare have become pressing concerns. Susan Ng and Hairianto Diman explores what appropriate steps should be taken if the need arises, with Benjamin Gaw, Director & Co-Head of Healthcare and Life sciences at Drew & Napier.

See omnystudio.com/listener for privacy information.